Kodiak Share Price

Kodiak Share Price

NASDAQ: KOD | Mid Cap | Healthcare
$97.20
-$0.78 (-0.8%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Kodiak Stock Performance

Open
$97.97
Prev. Close
$97.98
Circuit Range
N/A
Day Range
$96.81 - $100.64
Year Range
$19.38 - $112.68
Volume
21,191
Average Traded
$97.71

Kodiak Share Price Today

As of 22 November 2026, Kodiak Sciences Inc's share price is $97.20. The stock opened at $97.97, compared to its previous close of $97.98. During today's trading session, Kodiak Sciences Inc's share price traded between $96.81 and $100.64, with an average price of $98.73. Over the past 52 weeks, the stock has recorded a high of $112.68 and a low of $19.38. In terms of performance, Kodiak Sciences Inc's share price has risen by 165.18% over the last six months and is up 322.43% on a year-on-year basis.

Kodiak Share Price Chart

Line chart of the Kodiak price trend over the selected period. The price fell overall, ranging from 96.81 to 100.66, ending at 97.20.
$96.81$100.64
L
Show Current Price
H

Kodiak Stock Fundamentals & Key Indicators

Market Cap
$5.17B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.77
Revenue (TTM)
$0.00
Return On Equity (TTM)
-1962.77%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
-16.71%

Kodiak Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$56.74-$58.16-$65.64-$66.22
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-2.50%-12.86%-0.88%

Kodiak Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$333.82-$260.49-$176.21-$229.97
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A21.97%32.35%-30.51%

Kodiak Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets136.72163.64190.06180.62
Current Assets214.82171.94289.31486.01
Total Assets351.53335.58479.37666.63
Non Current Liabilities148.62159.72171.86177.97
Current Liabilities45.5325.5741.7352.5
Total Liabilities194.15185.29213.59230.46
Shareholders' Equity157.38150.29265.78436.17

Kodiak Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-136.01-117.32-154.18-206.46
Investing-0.51-0.76249.23-336.51
Financing178.30.50.031.9

About Kodiak

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Kodiak Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$99.52
$97.14
-2.17%
Oct 2026
$98.61
$99.29
+4.59%
Sep 2026
$37.01
$94.93
+142.79%
Aug 2026
$40.77
$39.10
-5.89%
Jul 2026
$38.22
$41.55
+6.64%
Jun 2026
$35.19
$38.96
+6.29%
May 2026
$43.91
$36.66
-15.86%
Apr 2026
$40.27
$43.56
+13.98%
Mar 2026
$27.14
$38.22
+42.83%
Feb 2026
$23.04
$26.76
+17.50%
Jan 2026
$28.23
$22.77
-18.50%
Dec 2025
$22.48
$27.95
+21.45%

Kodiak Share Price FAQs